Neely Mozaffarian is Chief Medical Officer for GentiBio, with more than 25 years of experience in molecular autoimmunity research. Prior to GentiBio, Neely led the strategy and execution of multiple pharmaceutical clinical development programs in Immunology/Autoimmunity, across all phases of drug development, including as Vice President, Immunology at Janssen/J&J, Senior Vice President at Ichnos Sciences, and as an executive/senior leader at Gilead, Eli Lilly, and AbbVie. Neely received her MD and PhD degrees from Albert Einstein College of Medicine in NY and completed her Internal Medicine residency training and Rheumatology fellowship at the University of Washington in Seattle. When not reading scientific articles, Neely heads to the coasts in order to be near, on, or in the water (and sometimes sneaks PubMed reading in at the same time).
Neely Mozaffarian, MD, PhD
Chief Medical Officer